Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wojta

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Thrombosis and Haemostasis|September 14, 2013
Obesity and vascular disease: From bench to bedsideJ Wojta, M Alessi
Thrombosis Research|March 1, 1987
Monoclonal antibodies against plasminogen and alpha-2-antiplasmin: binding to native and modified antigensE Hattey, J Wojta, B R Binder
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1994
Effect of notoginsenoside R1 on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cellsW Zhang, J Wojta, B R Binder
Journal of Vascular Research|July 1, 1997
Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expressionW J Zhang, J Wojta, B R Binder
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1996
IFN-gamma inhibits thrombin- and endotoxin-induced plasminogen activator inhibitor type 1 in human endothelial cellsM Gallicchio, P Hufnagl, J Wojta, et al.
The Journal of Infectious Diseases|June 1, 1992
Interactions between live Bartonella bacilliformis and endothelial cellsF U Garcia, J Wojta, R L Hoover
Cellular and Molecular Biology (Noisy-Le-Grand, France)|June 1, 1997
Effect of notoginsenoside R1 on the synthesis of components of the fibrinolytic system in cultured smooth muscle cells of human pulmonary arteryW J Zhang, J Wojta, B R Binder
Thrombosis Research|September 25, 2001
Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001K Huber, G Christ, J Wojta, et al.
Minerva Medica|October 30, 2010
Diabetic specific aspects in antithrombotic therapy in patients with coronary artery diseaseS Farhan, T Höchtl, J Wojta, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1997
Notoginsenoside R1 counteracts endotoxin-induced activation of endothelial cells in vitro and endotoxin-induced lethality in mice in vivoW J Zhang, J Wojta, B R Binder
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Thrombosis and Haemostasis|September 14, 2013
Obesity and vascular disease: From bench to bedsideJ Wojta, M Alessi
Thrombosis Research|March 1, 1987
Monoclonal antibodies against plasminogen and alpha-2-antiplasmin: binding to native and modified antigensE Hattey, J Wojta, B R Binder
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1994
Effect of notoginsenoside R1 on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cellsW Zhang, J Wojta, B R Binder
Journal of Vascular Research|July 1, 1997
Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expressionW J Zhang, J Wojta, B R Binder
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1996
IFN-gamma inhibits thrombin- and endotoxin-induced plasminogen activator inhibitor type 1 in human endothelial cellsM Gallicchio, P Hufnagl, J Wojta, et al.
The Journal of Infectious Diseases|June 1, 1992
Interactions between live Bartonella bacilliformis and endothelial cellsF U Garcia, J Wojta, R L Hoover
Cellular and Molecular Biology (Noisy-Le-Grand, France)|June 1, 1997
Effect of notoginsenoside R1 on the synthesis of components of the fibrinolytic system in cultured smooth muscle cells of human pulmonary arteryW J Zhang, J Wojta, B R Binder
Thrombosis Research|September 25, 2001
Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001K Huber, G Christ, J Wojta, et al.
Minerva Medica|October 30, 2010
Diabetic specific aspects in antithrombotic therapy in patients with coronary artery diseaseS Farhan, T Höchtl, J Wojta, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1997
Notoginsenoside R1 counteracts endotoxin-induced activation of endothelial cells in vitro and endotoxin-induced lethality in mice in vivoW J Zhang, J Wojta, B R Binder
Pageof 13